| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 65% | 13/20 |
| Female | 35% | 7/20 |
| Indifferent | 0% | 0/20 |
| Unknown | 0% | 0/20 |
| General | ||
| 20% | 4/20 | |
| 20% | 4/20 | |
| 15% | 3/20 | |
| 20% | 4/20 | |
| 15% | 3/20 | |
| 30% | 6/20 | |
| 95% | 19/20 | |
| 80% | 16/20 | |
| 65% | 13/20 | |
| 80% | 12/15 | |
| Neurology | ||
| 45% | 9/20 | |
| 15% | 3/20 | |
| 25% | 5/20 | |
| Facial abnormalities | ||
| 40% | 8/20 | |
| 75% | 15/20 | |
| 45% | 9/20 | |
| 90% | 18/20 | |
| Visual and hearing impairments | ||
| 15% | 3/20 | |
| 20% | 4/20 | |
| Heart | ||
| 55% | 11/20 | |
| Pulmonary | ||
| 10% | 2/20 | |
| Gastrointestinal | ||
| 50% | 10/20 | |
| Urogenital | ||
| 20% | 4/20 | |
| Skeleton | ||
| 45% | 9/20 | |
| Skin / Hair / Nails | ||
| 30% | 6/20 | |
| Endocrine / Immunological / Metabolic | ||
| 5% | 1/20 | |
| Metabolic | 0% | 0/20 |
| 5% | 1/20 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/20 |
| Inheritance | ||
| 77.8% | 14/18 | |
MEIS2